Crescent Biopharma Appoints David Lubner to Board of Directors
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Express News | GlycoMimetics Merger-Bound Crescent Appoints Joshua Brumm As CEO
Crescent Biopharma Appoints Joshua Brumm as Chief Executive Officer and Expands Leadership Team to Advance Pipeline of Potentially Best-in-Class Oncology Therapeutics
GLYCOMIMETICS Earnings Preview: Recent $GLYC Insider Trading, Hedge Fund Activity, and More
Cantor Fitzgerald Initiates GlycoMimetics(GLYC.US) With Buy Rating
GlycoMimetics Analyst Ratings
Cantor Fitzgerald Initiates GlycoMimetics at Overweight
Express News | GlycoMimetics : Following Termination, Co Will Not Have Any Material Financial or Other Obligations Under Agreement
Express News | GlycoMimetics : On Feb 19, Received Notice From Apollomics (Hong Kong) Limited Terminating Collaboration and License Agreement
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Trending Stocks Today | GCL Global Surges 107.59% Pre-Market
Express News | GlycoMimetics Inc - Co and Crescent Biopharma Amend Merger Agreement
GlycoMimetics | 10-K: FY2024 Annual Report
Express News | GlycoMimetics Inc - CEO Harout Semerjian and CFO Brian Hahn to Step Down
Britain's Avacta Recruits New CFO
Express News | GlycoMimetics Inc - on Dec 19, Nasdaq Grants GlycoMimetics 180 Days to Regain Compliance
GlycoMimetics | 10-Q: Q3 2024 Earnings Report
Crescent Biopharma to Present at Jefferies London Healthcare Conference 2024
GlycoMimetics Announces New Uproleselan Clinical Data Will Be Presented at ASH Annual Meeting